semaglutide lilly direct Knownwell joins Direct; Hims & Hers adds weight loss meds Lilly's Zepbound price cut could

Eriksen R, Gibson R, Aresu M, Heard A, Chan Q, Evangelou E, Gao H, Elliott P, Frost G

The goal of the administrations experiment is to improve the metabolic health of patients by covering GLP-1s and providing a healthy lifestyle support system, according to the CMS documents

Zepbound and semaglutide GLP-1 are both effective GLP-1 medications for weight loss, but they differ in their composition and delivery

A meta-analysis of over 80,000 patients reported 16: 16% reduction in kidney failure risk 18% reduction in worsening kidney function These benefits are thought to be largely driven by improvements in: Blood sugar control Blood pressure Body weight and inflammation Fertility and Reproductive Function GLP-1 therapies have also been linked to improvements in fertility outcomes, particularly in individuals with obesity or insulin resistance

Blue Cross Blue Shield of Massachusetts and Point32Health are discontinuing coverage of GLP-1 medications for weight loss, and CVS Caremark has restricted its formulary to Wegovy, removing Zepbound